A detailed history of State Of Wyoming transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, State Of Wyoming holds 30,379 shares of IRWD stock, worth $107,237. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,379
Previous 35,765 15.06%
Holding current value
$107,237
Previous $233,000 46.78%
% of portfolio
0.02%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.93 - $7.04 $21,166 - $37,917
-5,386 Reduced 15.06%
30,379 $124,000
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $1,283 - $1,980
-230 Reduced 0.64%
35,765 $233,000
Q1 2024

May 13, 2024

BUY
$8.32 - $15.45 $204,605 - $379,946
24,592 Added 215.66%
35,995 $313,000
Q4 2023

Feb 14, 2024

SELL
$8.79 - $11.51 $74,424 - $97,455
-8,467 Reduced 42.61%
11,403 $130,000
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $68,887 - $94,772
-8,350 Reduced 29.59%
19,870 $191,000
Q2 2023

Aug 14, 2023

BUY
$10.1 - $11.6 $14,847 - $17,052
1,470 Added 5.5%
28,220 $300,000
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $2,623 - $3,177
253 Added 0.95%
26,750 $281,000
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $30,789 - $38,657
3,110 Added 13.3%
26,497 $328,000
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $40,336 - $49,247
3,978 Added 20.5%
23,387 $242,000
Q2 2022

Aug 15, 2022

BUY
$11.05 - $12.72 $54,200 - $62,391
4,905 Added 33.82%
19,409 $224,000
Q1 2022

May 13, 2022

BUY
$10.61 - $12.88 $10,620 - $12,892
1,001 Added 7.41%
14,504 $182,000
Q4 2021

Feb 11, 2022

BUY
$10.86 - $13.95 $118,580 - $152,320
10,919 Added 422.56%
13,503 $158,000
Q3 2021

Feb 11, 2022

SELL
$11.92 - $13.92 $32,565 - $38,029
-2,732 Reduced 51.39%
2,584 $34,000
Q2 2021

Feb 11, 2022

BUY
$10.16 - $13.11 $34,940 - $45,085
3,439 Added 183.22%
5,316 $68,000
Q1 2021

Feb 08, 2022

BUY
$9.04 - $11.86 $16,968 - $22,261
1,877 New
1,877 $21,000

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.